September 1, 2019
PRO Consortium awarded contract to advance COAs for pediatric asthma
Related Posts
-
C-Path and EATRIS To Collaborate on RDCA-DAP -
FDA Awards C-Path Grant to Use Real-World Data to Generate Real-World Evidence in Neonates -
Rare Disease Cures Accelerator-Data and Analytics Platform First Year Milestones Highlighted at Virtual Workshop
-
Accelerating Drug Development for Rare Diseases through Data Sharing and Analysis -
How Math, Statistics, and Artificial Intelligence Can be Used to Develop Treatments for Major Diseases: Quantitative Medicine at the Critical Path Institute